Skip to main content
Top
Published in: Indian Journal of Pediatrics 10/2015

01-10-2015 | Review Article

Non Cystic Fibrosis Bronchiectasis

Authors: Anand K. Gupta, Rakesh Lodha, Sushil K. Kabra

Published in: Indian Journal of Pediatrics | Issue 10/2015

Login to get access

Abstract

Bronchiectasis is a pathological abnormality of the airways in which there is permanent dilatation and thickening of the airways. Precise incidence/prevalence in India is not known. Recent data suggests that about 1 % young children admitted in a hospital with pneumonia may develop bronchiectasis. Due to significant burden of pneumonia in young children in developing countries including India, it may be a significant problem that is possibly under recognized. Causes of bronchiectasis depend on the burden of respiratory infections and availability of the investigations for identification of the underlying cause. Post infectious causes are common in countries where infections are more common; however, since these countries are usually resource constrained and therefore, are not able to appropriately diagnose the other causes, leading to more than real overrepresentation of infections as a cause. In countries with less of infectious illnesses and good diagnostic facilities, malformations of airways, immune deficiency disorders and primary ciliary dyskinesia are common causes of bronchiectasis. High resolution CT scan of chest confirms the diagnosis. Treatment is supportive care and consists of maintenance of nutrition, airway clearance and antibiotics for exacerbations. Medical treatment is successful in the majority.
Literature
1.
go back to reference Roberts HJ, Hubbard R. Trends in bronchiectasis mortality in England and Wales. Respir Med. 2010;104:e981–5.CrossRef Roberts HJ, Hubbard R. Trends in bronchiectasis mortality in England and Wales. Respir Med. 2010;104:e981–5.CrossRef
2.
go back to reference Metcalfe TR, Edwards E, Byrnes C. New Zealand national incidence of bronchiectasis “too high” for a developed country. Arch Dis Child. 2005;90:737–40.PubMedCentralCrossRefPubMed Metcalfe TR, Edwards E, Byrnes C. New Zealand national incidence of bronchiectasis “too high” for a developed country. Arch Dis Child. 2005;90:737–40.PubMedCentralCrossRefPubMed
3.
go back to reference Chang AB, Bell SC, Torzillo PJ, et al; Extended Voting Group. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med J Aust. 2015;202:130. Chang AB, Bell SC, Torzillo PJ, et al; Extended Voting Group. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med J Aust. 2015;202:130.
4.
go back to reference Edmond K, Scott S, Korczak V, et al. Long term sequelae from childhood pneumonia; systematic review and meta-analysis. PLoS One. 2012;7:e31239. Edmond K, Scott S, Korczak V, et al. Long term sequelae from childhood pneumonia; systematic review and meta-analysis. PLoS One. 2012;7:e31239.
5.
go back to reference Rudan I, O'Brien KL, Nair H, et al; Child Health Epidemiology Reference Group (CHERG). epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health. 2013;3:010401. Rudan I, O'Brien KL, Nair H, et al; Child Health Epidemiology Reference Group (CHERG). epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health. 2013;3:010401.
6.
go back to reference Angrill J, Agusti C, De Celis R, et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med. 2001;164:1628–32.CrossRefPubMed Angrill J, Agusti C, De Celis R, et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med. 2001;164:1628–32.CrossRefPubMed
7.
go back to reference Loukides S, Bouros D, Papatheodorou G, Lachanis S, Panagou P, Siafakas NM. Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest. 2002;121:81–7.CrossRefPubMed Loukides S, Bouros D, Papatheodorou G, Lachanis S, Panagou P, Siafakas NM. Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest. 2002;121:81–7.CrossRefPubMed
8.
9.
go back to reference Verhagen LM, de Groot R. Recurrent, protracted and persistent lower respiratory tract infection: a neglected clinical entity. J Infect. 2015;71:S106–11.CrossRefPubMed Verhagen LM, de Groot R. Recurrent, protracted and persistent lower respiratory tract infection: a neglected clinical entity. J Infect. 2015;71:S106–11.CrossRefPubMed
10.
go back to reference Li AM, Sonnappa S, Lex C, et al. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur Respir J. 2005;26:8–14.CrossRefPubMed Li AM, Sonnappa S, Lex C, et al. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur Respir J. 2005;26:8–14.CrossRefPubMed
11.
go back to reference Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatr Pulmonol. 2001;32:175–8.CrossRefPubMed Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatr Pulmonol. 2001;32:175–8.CrossRefPubMed
12.
go back to reference Eastham KM, Fall AJ, Mitchell L, Spencer DA. Paediatric lung disease: the need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax. 2004;59:324–7.PubMedCentralCrossRefPubMed Eastham KM, Fall AJ, Mitchell L, Spencer DA. Paediatric lung disease: the need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax. 2004;59:324–7.PubMedCentralCrossRefPubMed
14.
go back to reference Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E. Non-cystic fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration. 2005;72:233–8.CrossRefPubMed Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E. Non-cystic fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration. 2005;72:233–8.CrossRefPubMed
15.
go back to reference Kumar A, Lodha R, Kumar P, Kabra SK. Non-cystic fibrosis bronchiectasis in children: clinical profile, etiology and outcome. Indian Pediatr. 2015;52:35–7.CrossRefPubMed Kumar A, Lodha R, Kumar P, Kabra SK. Non-cystic fibrosis bronchiectasis in children: clinical profile, etiology and outcome. Indian Pediatr. 2015;52:35–7.CrossRefPubMed
16.
go back to reference Hill AT, Pasteur M, Cornford C, Welham S, Bilton D. Primary care summary of the British thoracic society guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J. 2011;20:135–40.CrossRefPubMed Hill AT, Pasteur M, Cornford C, Welham S, Bilton D. Primary care summary of the British thoracic society guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J. 2011;20:135–40.CrossRefPubMed
17.
go back to reference Swensen SJ, Aughenbaugh GL, Brown LR. High-resolution computed tomography of the lung. Mayo Clin Proc. 1989;64:1284–94.CrossRefPubMed Swensen SJ, Aughenbaugh GL, Brown LR. High-resolution computed tomography of the lung. Mayo Clin Proc. 1989;64:1284–94.CrossRefPubMed
18.
go back to reference Kuhn JP, Brody AS. High-resolution CT of pediatric lung disease. Radiol Clin N Am. 2002;40:89–110.CrossRefPubMed Kuhn JP, Brody AS. High-resolution CT of pediatric lung disease. Radiol Clin N Am. 2002;40:89–110.CrossRefPubMed
20.
go back to reference Kang EY, Miller RR, Muller NL. Bronchiectasis: comparison of preoperative thin-section CT and pathologic findings in resected specimens. Radiology. 1995;195:649–54.CrossRefPubMed Kang EY, Miller RR, Muller NL. Bronchiectasis: comparison of preoperative thin-section CT and pathologic findings in resected specimens. Radiology. 1995;195:649–54.CrossRefPubMed
21.
go back to reference Mansour Y, Beck R, Danino J, Bentur L. Resolution of severe bronchiectasis after removal of long-standing retained foreign body. Pediatr Pulmonol. 1998;25:130–2.CrossRefPubMed Mansour Y, Beck R, Danino J, Bentur L. Resolution of severe bronchiectasis after removal of long-standing retained foreign body. Pediatr Pulmonol. 1998;25:130–2.CrossRefPubMed
22.
go back to reference Karakoç F, Karadağ B, Akbenlioğlu C, et al. Foreign body aspiration: what is the outcome? Pediatr Pulmonol. 2002;34:30–6.CrossRefPubMed Karakoç F, Karadağ B, Akbenlioğlu C, et al. Foreign body aspiration: what is the outcome? Pediatr Pulmonol. 2002;34:30–6.CrossRefPubMed
23.
go back to reference Gaillard EA, Carty H, Heaf D, Smyth RL. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol. 2003;47:215–20.CrossRefPubMed Gaillard EA, Carty H, Heaf D, Smyth RL. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol. 2003;47:215–20.CrossRefPubMed
24.
25.
go back to reference Montella S, Maglione M, Bruzzese D, et al. Magnetic resonance imaging is an accurate and reliable method to evaluate non-cystic fibrosis paediatric lung disease. Respirology. 2012;17:87–91.CrossRefPubMed Montella S, Maglione M, Bruzzese D, et al. Magnetic resonance imaging is an accurate and reliable method to evaluate non-cystic fibrosis paediatric lung disease. Respirology. 2012;17:87–91.CrossRefPubMed
26.
go back to reference Kabra SK, Lodha R, Ramesh P, Sarthi M. Fiberoptic bronchoscopy in children an audit from a tertiary care center. Indian Pediatr. 2008;45:917–9.PubMed Kabra SK, Lodha R, Ramesh P, Sarthi M. Fiberoptic bronchoscopy in children an audit from a tertiary care center. Indian Pediatr. 2008;45:917–9.PubMed
27.
go back to reference Kabra SK, Kabra M, Lodha R, Shastri S. Cystic fibrosis in India. Pediatr Pulmonol. 2007;42:1087–94.CrossRefPubMed Kabra SK, Kabra M, Lodha R, Shastri S. Cystic fibrosis in India. Pediatr Pulmonol. 2007;42:1087–94.CrossRefPubMed
28.
go back to reference Popatia R, Haver K, Casey A. Primary ciliary dyskinesia: an update on new diagnostic modalities and review of the literature. Pediatr Allergy Immunol Pulmonol. 2014;27:51–9.PubMedCentralCrossRefPubMed Popatia R, Haver K, Casey A. Primary ciliary dyskinesia: an update on new diagnostic modalities and review of the literature. Pediatr Allergy Immunol Pulmonol. 2014;27:51–9.PubMedCentralCrossRefPubMed
30.
go back to reference Agarwal R, Chakrabarti A, Shah A, et al; ABPA complicating asthma ISHAM working group. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43:850–73.CrossRefPubMed Agarwal R, Chakrabarti A, Shah A, et al; ABPA complicating asthma ISHAM working group. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43:850–73.CrossRefPubMed
31.
go back to reference Welsh EJ, Evans DJ, Fowler SJ, Spencer S. Interventions for bronchiectasis: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2015;7:CD010337. [Epub ahead of print] Welsh EJ, Evans DJ, Fowler SJ, Spencer S. Interventions for bronchiectasis: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2015;7:CD010337. [Epub ahead of print]
32.
go back to reference Snijders D, Fernandez Dominguez B, Calgaro S, et al. Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: is there evidence? Int J Immunopathol Pharmacol. 2015;28:150–9. Snijders D, Fernandez Dominguez B, Calgaro S, et al. Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: is there evidence? Int J Immunopathol Pharmacol. 2015;28:150–9.
33.
go back to reference Bothra M, Lodha R, Kabra SK. Tobramycin for the treatment of bacterial pneumonia in children. Expert Opin Pharmacother. 2012;13:565–71.CrossRefPubMed Bothra M, Lodha R, Kabra SK. Tobramycin for the treatment of bacterial pneumonia in children. Expert Opin Pharmacother. 2012;13:565–71.CrossRefPubMed
34.
go back to reference Kuruvilla M, de la Morena MT. Antibiotic prophylaxis in primary immune deficiency disorders. J Allergy Clin Immunol Pract. 2013;1:573–82.CrossRefPubMed Kuruvilla M, de la Morena MT. Antibiotic prophylaxis in primary immune deficiency disorders. J Allergy Clin Immunol Pract. 2013;1:573–82.CrossRefPubMed
35.
go back to reference Serisier DJ, Martin ML. Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations. Respir Med. 2011;105:946–9.CrossRefPubMed Serisier DJ, Martin ML. Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations. Respir Med. 2011;105:946–9.CrossRefPubMed
36.
go back to reference Anwar GA, Bourke SC, Afolabi G, Middleton P, Ward C, Rutherford RM. Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. Respir Med. 2008;102:1494–6.CrossRefPubMed Anwar GA, Bourke SC, Afolabi G, Middleton P, Ward C, Rutherford RM. Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. Respir Med. 2008;102:1494–6.CrossRefPubMed
Metadata
Title
Non Cystic Fibrosis Bronchiectasis
Authors
Anand K. Gupta
Rakesh Lodha
Sushil K. Kabra
Publication date
01-10-2015
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 10/2015
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-015-1866-4

Other articles of this Issue 10/2015

Indian Journal of Pediatrics 10/2015 Go to the issue